Making a personalized T cell therapy for cancer patients currently takes at least six months. Scientists have shown that the laborious first step of identifying tumor-reactive T cell receptors for ...
Making a personalized T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have ...
The manufacturing process for personalized T-cell therapies hardly begins before it stalls. Why? Right at the start, there is a severe bottleneck: the need to identify patient-derived, tumor-reactive ...
Please provide your email address to receive an email when new articles are posted on . A machine learning classifier was trained on capnogram features. The model’s probability output inversely ...
SHENZHEN, China, May 2, 2025 /PRNewswire/ -- MicroAlgo Inc. (MLGO) (the "Company" or "MicroAlgo") announced today the launch of their latest classifier auto-optimization technology based on ...
Lyme disease is a high-incidence infectious disease with a global prevalence of 14.5% of the world's population. Two-tier serology is currently the primary diagnostic test for Lyme disease; however, ...
Making a personalized T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results